Misc. news stories

A new study has found a positive association between mindfulness practice, psychedelic use, and overall psychological wellbeing. The findings have been published in the Journal of Psychoactive Drugs.

A new study has linked life satisfaction to the chemistry in our brains. People that release more of the neurochemical oxytocin are kinder to others and tend to be more satisfied with their lives.

As a legal psychedelic industry nears, facilitators fight for their right to remain underground.

People with depressive symptoms appear to think it is relatively important that guides for psilocybin-assisted psychotherapy have personally used the psychedelic substance themselves, according to a new study published in the Journal of Psychoactive Drugs.

The drug MDMA (3,4-methylenedioxymethamphetamine) might not produce depressive “comedowns” when used in a controlled clinical setting, according to new research published in the Journal of Psychopharmacology.

Psychedelic use has been proposed as a treatment for various substance use disorders, leading people to question if it would be an effective treatment for opioid abuse. A study published in Nature: Scientific Reports suggests that psilocybin use, but no other psychedelics, was linked to lower odds of opioid abuse.

It’s high time we had a sensible conversation about cannabis reform. From Canada to Georgia, Mexico to Malta, countries around the world are changing their laws. But in the UK the substance continues to be banned. We are failing to keep up with global trends and new thinking.

A tranche of documents released to Motherboard through FOIA show the research priorities of the secretive Advanced Aerospace Weapons Systems Application Program.

In a country with conflicting legal and social attitudes to marijuana, this idyllic cafe wants to break the stigma around the persecuted plant.

After a shock injury on a reef in Indonesia in 2018, he pushed into frontiers that athletes, let alone modern science, are only just beginning to explore.

Image from: Shalom Jacobovitz (Wiki Commons)

Psilocybin, a drug found in magic mushrooms, appears to free up the brains of people with severe depression in a way that other antidepressants do not, a study has found.

For the past several decades, psychedelics have been widely stigmatized as dangerous illegal drugs. But a recent surge of academic research into their use to treat psychiatric conditions is spurring a recent shift in public opinion.

The psychedelic substance psilocybin causes transient changes to the sleep-wake architecture of laboratory mice, according to new preliminary research published in Translational Psychiatry. The findings provide new details about how the drug impacts sleep-related brain activity.

The findings, published March 28 in Frontiers in Psychology, reveal that higher ratings of mystical-type experiences, which often include a sense that everything is alive, were associated with greater increases in the attribution of consciousness.

Image from: Air article (Wiki Commons)